Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Neither is currently licensed for routine clinical use in the UK
Many companies claim third-party tested, but testing only matters when the laboratories are credible and the results are actually reviewed
Unlike many pharmaceutical compounds, GHK-Cu does not appear to produce tolerance with continued use
It interacts with the nitric oxide pathway, providing benefits like improved oxygen transport
Food and Drug Administration for the treatment of cognitive decline, dementia, Alzheimers disease, memory loss, or other neurological conditions
Research shows it can increase vascularization by 129 to 152 percent in injured tissues
US$ 21.76
US$ 21.68
US$ 23.91
US$ 25.29
